Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in XPH
29.3%
% of XPH's 41 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ZOETIS INC | 4.6% | 3.7% | 3.7% |
|
JOHNSON & JOHNSON | 6.6% | 3.7% | 3.7% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 3.7% | 3.7% |
|
ELI LILLY & CO | 11.9% | 3.7% | 3.7% |
|
PFIZER INC | 4.4% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 8.2% |
|
ABBVIE INC | 6.5% |
 |
NOVARTIS AG-ADR | 5.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
|
CENCORA INC | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.9% |
|
MCKESSON CORP | 4.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% |
PPH Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.9% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
CORCEPT THERAPEUTICS INC | -3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.6% |
|
ROYALTY PHARMA PLC CLASS A | -3.5% |
|
EDGEWISE THERAPEUTICS, INC. | -3.2% |
 |
PERRIGO CO | -2.9% |
|
PACIRA PHARMACEUTICALS INC | -2.9% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.8% |
|
ELANCO ANIMAL HEALTH, INC. | -2.7% |